Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
WHO
Manufacturing
CSL’s Seqirus unit boasts bigger batch of flu vaccines
CSL Seqirus, a unit of the Australian biopharma CSL, touted the availability of more influenza vaccines in the U.S. ahead of the upcoming flu season.
Joseph Keenan
Sep 30, 2026 9:27am
Innoviva scores FDA nod for gonorrhea drug one day after GSK
Dec 12, 2025 3:31pm
Orchid granted license to produce antibiotic to meet global need
Sep 12, 2023 9:55am
More COVID vaccine market uncertainty on tap for pharma: analyst
Apr 10, 2023 11:53am
GSK's rotavirus shot runs short due to manufacturing issues
Aug 11, 2022 4:00pm
Bavarian Nordic wins monkeypox vaccine approval in Europe
Jul 25, 2022 11:45am